Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.
about
Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.
description
clinical trial
@en
name
Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.
@ast
Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.
@en
type
label
Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.
@ast
Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.
@en
prefLabel
Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.
@ast
Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.
@en
P1476
Baricitinib Combined With Anti ...... 19: an Open-label, Pilot Study
@en
P17
P1813
BARI-COVID
@en
P3098
NCT04320277
P580
2020-03-16T00:00:00Z
P582
2020-04-30T00:00:00Z